Promoting equitable access to hepatitis C treatment for Indo-Chinese injecting drug users

被引:6
作者
Coupland, Heidi [1 ,2 ]
Day, Carolyn [3 ]
Levy, Miriam T. [4 ,5 ]
Maher, Lisa [2 ]
机构
[1] Univ New S Wales, St Vincents Med Ctr, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia
[2] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia
[3] Univ Sydney, Cent Clin Sch, Sydney Med Sch, Sydney, NSW 2006, Australia
[4] Univ New S Wales, S Western Sydney Area Hlth Serv, Sydney, NSW, Australia
[5] Univ New S Wales, Fac Med, Sydney, NSW, Australia
关键词
injecting drug user; hepatitis C treatment; marginalisation; cultural diversity; VIRUS HCV INFECTION; BLOOD-BORNE VIRUSES; ETHNIC-VIETNAMESE; RISK BEHAVIORS; BARRIERS; THERAPY; EPIDEMIOLOGY; MELBOURNE; KNOWLEDGE; ATTITUDES;
D O I
10.1071/HE09234
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Issue addressed: Increasing the uptake of hepatitis C treatment by injecting drug users (IDUs) is a key strategy in addressing the escalating disease burden of chronic hepatitis C virus (HCV) infection in Australia. Little is known about barriers to treatment uptake among culturally diverse groups of IDUs. Indo-Chinese IDUs represent a marginalised group with high rates of incident and prevalent HCV infection. Methods: An ethnographic study was conducted to explore barriers to HCV treatment uptake experienced by Indo-Chinese IDUs and inform the development of policies and practices that promote access to treatment. Following a baseline interview, participants (n=23) received a brief intervention about HCV treatment and an offer of facilitated referral to a tertiary liver clinic. Follow-up interviews were conducted three and six months post intervention, to explore decision-making about treatment-seeking and experiences accessing the clinic. Results: While 'getting rid of' HCV was regarded as highly desirable, only three participants were assessed for treatment. For most participants, seeking treatment was not seen as feasible given social and structural barriers related to their drug use, lack of resources and support. Institutional barriers included the clinic's administrative procedures, limited flexibility and apparent reluctance to consider current IDUs suitable candidates for treatment. Conclusions: Resources and support, flexible, low threshold approaches to assessment and a willingness to provide treatment to current IDUs, would promote equitable access to treatment among these groups.
引用
收藏
页码:234 / 240
页数:7
相关论文
共 44 条
[1]   HEPACOM: multicenter, observational prospective study of outcome and monitoring of HCV positive antiviral-nalive patients managed in the French health care system [J].
Agostini, Helene ;
Castera, Laurent ;
Melin, Pascal ;
Cattan, Laurent ;
Roudot-Thoraval, Francoise .
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2007, 31 (12) :1074-1080
[2]  
[Anonymous], 2006, Census of Population and Housing
[3]  
Arthur Kleinman., 1997, Social Suffering
[4]  
Braun V, 2006, Qualitative Research in Psychology, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]
[5]   Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients [J].
Bruggmann, P. ;
Falcato, L. ;
Dober, S. ;
Helbling, B. ;
Keiser, O. ;
Negro, F. ;
Meili, D. .
JOURNAL OF VIRAL HEPATITIS, 2008, 15 (10) :747-752
[6]  
Commonwealth Department of Health and Ageing, 2005, NAT HEP C STRAT 2005
[7]  
COUPLAND H, 2008, RISK RESILIENCE REDE
[8]   Treatment of chronic hepatitis C in active drug users [J].
Davis, GL ;
Rodrigue, JR .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) :215-217
[9]   Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia [J].
Doab, A ;
Treloar, C ;
Dore, GJ .
CLINICAL INFECTIOUS DISEASES, 2005, 40 :S313-S320
[10]  
DUTERTRE S, 2008, IMPROVING ACCESS HEP